Synteract Acquires Dermatology Specialist CRO Cu-Tech

Jul 11, 2018
By Applied Clinical Trials Editors

Synteract, a CRO providing full-service Phase I-IV clinical trials, has acquired Cu-Tech, a dermatology specialist CRO. With this acquirement, Synteract has created a dedicated center of dermatology development.

Read the full release here.

native1_300x100
lorem ipsum